Purchase Order 75A50121P00003

Award Date 10/26/20
Potential Completion Date 10/25/21
Potential Value $7M
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $53.6 million definitive contract to Monogram Biosciences, Inc. to provide high throughput SARS-CoV-2 neutralizing antibody immunoassays for qualifying variants and testing of human serum samples. The contract is a firm fixed price agreement that will be performed by Monogram Biosciences, Inc. in South San Francisco, California over a four year period from November 2021 through...
This firm fixed-price contract was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Monogram Biosciences, Inc., a for-profit subsidiary of Laboratory Corporation of America Holdings. The $9,109,520.00 contract requires Monogram Biosciences to provide rapid screening and testing services to evaluate the efficacy of medical countermeasures against SARS-CoV-2 pseudoviruses, including emerging variants. The base period...
This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Monogram Biosciences, Inc. for $17,665.00. The contract is for the PHENOSENSE HIV NEUT AB ASSAY, which provides testing and research services. Monogram Biosciences is a for-profit subsidiary of Laboratory Corporation of America Holdings that operates a laboratory in California. This award was not set aside for any...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Monogram Biosciences, Inc., a subsidiary of Laboratory Corporation of America Holdings. The $22,665.00 contract is for Monogram Biosciences to provide the "PHENOSENSE HIV NEUT AB ASSAY, CAT # NEUT.2VIRUSES" product. This contract was not set aside for any socioeconomic categories. Monogram Biosciences is an...
The Department of Health and Human Services Office of the Assistant Secretary for Administration awarded Laboratory Corporation of America a $4.59 million firm fixed price purchase order to provide COVID-19 laboratory testing services from March 18, 2020 to August 14, 2020. The purpose of this ratification was to cover services already provided from March 18 to May 5, 2020 totaling $4.59 million. Laboratory Corporation of America, as the prime contractor, will perform the testing at its...
This purchase order ratifies a previous contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Administration to Quest Diagnostics Incorporated for COVID-19 laboratory testing services. The contract value is $6.5 million and provides testing from March 18, 2020 through July 31, 2020. As the prime contractor, Quest Diagnostics will deliver coronavirus diagnostic and surveillance testing to support the Office of the Assistant Secretary for...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company that produces molecular diagnostic testing systems and assays. The contract is for the delivery of APTIMA SARS-CoV-2 tests to detect COVID-19, with a potential value of $745,185.00 and a completion date of March 31, 2023. The contract is part of the agency's efforts to procure necessary medical supplies related to the Coronavirus COVID-19 national interest...
This is a $9,850,000.00 firm fixed price purchase order awarded by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) to Luminex Corporation. The contract is to expand the use of Luminex's ARIES SARS-CoV-2 assay, which is a molecular diagnostic test for COVID-19. This award was not set aside for any specific business type. Luminex is a manufacturer of biological testing technologies, including multiplex diagnostic solutions,...
Hologic, Inc. was awarded a $10.986 million firm fixed price purchase order by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to provide APTIMA SARS-COV-2 tests on Hologic Panther systems. The tests and associated diagnostic equipment will support the federal government's response efforts to the Coronavirus COVID-19 pandemic and will be delivered to a location in San Diego, California over a one year period concluding in August...
Hologic, Inc. was awarded a $6 million firm fixed price purchase order by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to expand production capacity for the Panther Fusion SARS-CoV-2 assay. The contract will support the agency's COVID-19 response efforts through increased domestic manufacturing of molecular diagnostic tests to detect the virus that causes coronavirus disease 2019. Performance will occur at Hologic's facility in San...

This purchase order, valued at $6.96 million, was awarded by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to Monogram Biosciences, Inc. to establish high-throughput SARS-CoV-2 neutralizing antibody immunoassay capability and test human serum samples. As a subsidiary of Laboratory Corporation of America Holdings, Monogram will perform this work establishing a testing capability and analyzing samples at its facility in South San Francisco, California over the one-year base period of performance from October 2020 to October 2021 under a firm fixed price contract. The funding supports the agency's efforts to respond to the Coronavirus Disease 2019 pandemic by expanding serological testing capacity and analyzing serum samples to detect the presence of SARS-CoV-2 neutralizing antibodies.

Generated 12/29/23, 2:53 PM